Resultats de la cerca - Michael A. Pulsipher

Refinar resultats
  1. 1
    Hypogammaglobulinemia due to CAR T‐cell therapy

    Hypogammaglobulinemia due to CAR T‐cell therapy per Andrew Doan, Michael A. Pulsipher

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  2. 2
    High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant?

    High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant? per Michael A. Pulsipher, Christina Peters, Ching‐Hon Pui

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL

    How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL per Regina M. Myers, Nirali N. Shah, Michael A. Pulsipher

    Publicat 2022
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse

    Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherape... per Michael A. Pulsipher, Peter Bader, Thomas Klingebiel, Laurence J.N. Cooper

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria

    Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria per John D. Phillips, David P. Steensma, Michael A. Pulsipher, Gerald J. Spangrude, James P. Kushner

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association

    Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association per B. E. Shaw, Dennis L. Confer, William Ying Khee Hwang, Derwood Pamphilon, Michael A. Pulsipher

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes

    NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive O... per Susan K. Parsons, Sean Phipps, Lillian Sung, K. Scott Baker, Michael A. Pulsipher, Kirsten K. Ness

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks

    NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bon... per Christopher C. Dvorak, Clarisa R. Gracia, Jean E. Sanders, Edward Y. Cheng, K. Scott Baker, Michael A. Pulsipher, Anna Petryk

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States

    Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States per Paul V. O’Donnell, Tanya L. Pedersen, Dennis L. Confer, J. Douglas Rizzo, Michael A. Pulsipher, David Stroncek, Susan F. Leitman, Paolo Anderlini

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Long-Term Organ Damage and Dysfunction

    National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After P... per Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update

    High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update per Rani E. George, Shuli Li, Cheryl Medeiros-Nancarrow, Donna Neuberg, Karen Marcus, Robert C. Shamberger, Michael A. Pulsipher, Stephan A. Grupp, Lisa Diller

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic Anemia

    Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic Anemia per Joseph H. Antin, H. Joachim Deeg, Sandra Korman, Carmem Bonfim, Ryotaro Nakamura, Mary M. Horowitz, Daniel J. Weisdorf, Mary Eapen, Michael A. Pulsipher

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose

    Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose per Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Susan F. Leitman, Paolo Anderlini, John P. Klein, Mary M. Horowitz, J. Philip Miller, Roberta King, Dennis L. Confer

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report

    National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report per Saro H. Armenian, Wassim Chemaitilly, Marcus Y. Chen, Eric J. Chow, Christine Duncan, Lee W. Jones, Michael A. Pulsipher, Alan T. Remaley, Alicia Rovó, Nina Salooja, Minoo Battiwalla

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia

    Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia per Matthew J. Oberley, Paul S. Gaynon, Deepa Bhojwani, Michael A. Pulsipher, Rebecca Gardner, Matthew Hiemenz, Jianling Ji, Jennifer Han, Maurice R.G. O’Gorman, Alan S. Wayne, Gordana Raca

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

    Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hemato... per Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Amelia Langston, Richard T. Maziarz, Michael A. Pulsipher, Peter A. McSweeney, Rainer Storb

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

    Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation per Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Willis H. Navarro, John E. Levine, J. Philip Miller, Bronwen E. Shaw, Paul V. O’Donnell, Navneet S. Majhail, Dennis L. Confer

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review

    The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review per Denise M Oliansky, Bruce Camitta, Paul S. Gaynon, Michael L. Nieder, Susan K. Parsons, Michael A Pulsipher, Hildy Dillon, Thomas A Ratko, Donna A. Wall, Philip L. McCarthy, Theresa Hahn

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Immunogenicity of CAR T cells in cancer therapy

    Immunogenicity of CAR T cells in cancer therapy per Dimitrios L. Wagner, Enrico Fritsche, Michael A. Pulsipher, Nabil Ahmed, Mohamad Hamieh, Meenakshi Hegde, Marco Ruella, Barbara Savoldo, Nirali N. Shah, Cameron J. Turtle, Alan S. Wayne, Mohamed Abou‐El‐Enein

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

    Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC03... per Michael A. Pulsipher, Kenneth M. Boucher, Donna A. Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, Richard Kadota

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: